SOPHiA, GENETICS

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

SOPHiA GENETICS AstraZeneca Switzerland Massachusetts

en | GB0009895292 | SOPHIA | boerse | 67947915 |